Edit
Merck Global Health Innovation Fund
https://www.merckghifund.com/Last activity: 25.09.2024
Active
Investment Type: Venture Capital
Portfolio 1
Date | Name | Website | Total Raised | Location |
25.03.2023 | Pragma Bio | pragmabio.com | $10M | United Sta... |
Mentions in press and media 19
Date | Title | Description |
25.09.2024 | Qure.ai Raises $65M to Expand Healthcare AI Solutions Globally | What You Should Know: – Qure.ai, a prominent global innovator in healthcare AI, has successfully closed a $65M in Series D funding round led by Lightspeed and 360 ONE Asset, with contributions from Merck Global Health Innovation Fund and Ka... |
25.06.2024 | Qure.ai Gets Investment from Merck Global Health Innovation Fund to Enhance Healthcare AI | AI to power early identification and management of lung cancer and other diseases Merck Global Health Innovation Fund has made a strategic investment into Qure.ai as part of its Series D round. This funding will go towards investing into fo... |
19.12.2023 | UNP Scores $32M for AI-Powered Macrocycle Therapeutics | What You Should Know: – Unnatural Products, Inc. (UNP), a biotech company harnessing the power of AI and chemistry to design the next generation of targeted therapeutics, has secured $32M in Series A funding. – Led by Merck Global Health In... |
30.11.2023 | Culmination Bio Raises $10M to Bring Longitudinal Health Data to Biopharma | What You Should Know: Culmination Bio, a company building the largest disease-agnostic patient data intelligence platform, today announced a $10 million investment from Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures. As ... |
06.07.2023 | ‘Hope Is Not a Business Model’: Digital Health Fundraising Advice from 2 VCs | Over the past year or so, the digital health fundraising landscape has transitioned from a climate that where companies had more power (given the extraordinary interest in all things tech) to one where investors have more power. In 2021, th... |
22.11.2022 | Cancer drugs forecasting startup Turbine secures €20 million series A | Turbine, a London-based startup that's working on cell simulators to predict how patients might benefit from new targeted cancer treatments, has raised €20 million in new funding. The round is billed as a series A and has attracted backing ... |
27.07.2022 | Syapse Raises $35M to Expand Learning Health Network | What You Should Know: – Syapse raises $35M led by an affiliate of Innovatus Capital Partners, LLC (Innovatus)to tackle the challenge of understanding, preventing, and treating complex cancers. – The investment will allow Syapse to expand it... |
03.03.2022 | Black Female Co-founders CancerIQ Raises $14M to Improve Cancer Early Detection and Prevention | CancerIQ Co-Founders Feyi Olopade Ayodele & Olufunmilayo (Funmi) Olopade, MD What You Should Know: – CancerIQ, a Chicago-based platform powering early cancer detection and prevention across broad patient populations, announced today it ... |
14.01.2022 | Verana Health Raises $150M to Expand Real-World Data Network | What You Should Know: Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights from an exclusive real-world data network, today announced a $150 million Series E funding round led by Johnson... |
11.01.2022 | Transcarent Raises $200M to Expand Care Platform for Self-Insured Employers | What You Should Know: – Transcarent, a new and different health and care experience company for employees of self-insured employers and their families, today announced a $200M Series C round led by Kinnevik and Human Capital, with participa... |
Show more